BELLICUM PHARMACEUTICALS INC's ticker is BLCM and the CUSIP is 079481107. A total of 90 filers reported holding BELLICUM PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 2.58 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $223,000 | -49.4% | 130,984 | 0.0% | 0.00% | -50.0% |
| Q1 2019 | $441,000 | +15.4% | 130,984 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $382,000 | -60.6% | 130,984 | -16.7% | 0.00% | -50.0% |
| Q3 2018 | $969,000 | -14.9% | 157,297 | +1.9% | 0.00% | 0.0% |
| Q2 2018 | $1,139,000 | +12.3% | 154,297 | -0.2% | 0.00% | 0.0% |
| Q1 2018 | $1,014,000 | -22.5% | 154,547 | -0.6% | 0.00% | -33.3% |
| Q4 2017 | $1,308,000 | -27.3% | 155,547 | -0.1% | 0.01% | -25.0% |
| Q3 2017 | $1,798,000 | +31.7% | 155,647 | +33.2% | 0.01% | +14.3% |
| Q2 2017 | $1,365,000 | +60.0% | 116,892 | +69.2% | 0.01% | +40.0% |
| Q1 2017 | $853,000 | -9.4% | 69,100 | 0.0% | 0.01% | -16.7% |
| Q4 2016 | $941,000 | +56.1% | 69,100 | +128.1% | 0.01% | +50.0% |
| Q3 2016 | $603,000 | +53.4% | 30,300 | 0.0% | 0.00% | +33.3% |
| Q2 2016 | $393,000 | +36.9% | 30,300 | -1.3% | 0.00% | +50.0% |
| Q1 2016 | $287,000 | -53.3% | 30,700 | +1.3% | 0.00% | -60.0% |
| Q4 2015 | $614,000 | +181.7% | 30,300 | +102.0% | 0.01% | +150.0% |
| Q3 2015 | $218,000 | -22.4% | 15,000 | +13.6% | 0.00% | -33.3% |
| Q2 2015 | $281,000 | – | 13,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|